Autoimmune diseases disproportionately affect women, with 80% of individuals suffering from these conditions being female. These diseases often lead to chronic and debilitating symptoms. Early and accurate diagnosis is crucial for effective management. Multi-analyte differentiation of protein biomarkers holds immense promise in distinguishing between various autoimmune diseases, enabling tailored treatment plans. To improve patient outcomes, there is a critical need for point-of-care devices that can rapidly and reliably monitor these biomarkers. This would empower patients to actively participate in their healthcare and facilitate timely interventions.
Bioengineers at the Wyss are developing highly sensitive, point-of-care, multiplexed electrochemical sensors for the rapid detection of autoantibodies using non-invasive biological fluids. This technology could revolutionize patient care by enabling timely monitoring of disease progression, facilitating early interventions, and empowering patients with greater control over their health.